Australia's Probiotec hits 4-month high on nod for Pyridam buyout

Probiotec

10/05/2024 04:28

** Shares of Probiotec  PBP.AX  rise as much as 1.7% to
A$2.92, their highest level since Jan. 9
    ** Stock on track for its fourth straight day of gains
    ** Pharmaceutical co gets government clearance to be
acquired by PYFA Australia (Pyridam Sub)
    ** Over 106,000 shares traded vs 30-day avg of ~87k shares
    ** Stock down 1% this year, as of last close

 (Reporting by Megha Rani in Bengaluru)
 ((Megha.Rani2@thomsonreuters.com;))